Isabelle Aubry

673 citations
26 papers · 468 indexed · h-index 13
Topics
Protein Tyrosine Phosphatases (14 papers)Galectins and Cancer Biology (6 papers)Cytokine Signaling Pathways and Interactions (4 papers)

In The Last Decade

Isabelle Aubry

25 papers receiving 465 citations

Peers

Isabelle Aubry
Comparison fields: 5 of 73
  • Molecular Biology 233
  • Rheumatology 113
  • Immunology 91
  • Oncology 62
  • Ophthalmology 43
Replace Tao You with:
Tao You China
Tae Jung Jang South Korea
Constanze Schwarz Germany
C.E. Whittles United Kingdom
Raquel Grau Spain
Naomi Brook Australia
Peng Luo China
Michael J. Heiferman United States
Phyllus Y. Mong United States
Elizabeth Siebert United States
Isabelle Aubry relative to Tao You China Tao You's profile →
Citations per field
00.5×6.1×
Tao You · 1×
Citations per year

Countries citing papers authored by Isabelle Aubry

Since Specialization
Citations

This map shows the geographic impact of Isabelle Aubry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Aubry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Aubry more than expected).

Fields of papers citing papers by Isabelle Aubry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Aubry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Aubry. The network helps show where Isabelle Aubry may publish in the future.

Co-authorship network of co-authors of Isabelle Aubry

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Aubry. A scholar is included among the top collaborators of Isabelle Aubry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Aubry. Isabelle Aubry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 1
4 3
5 1
6 2
7 15
8 12
9 9
10 10
11 28
12 10
13 17
14 15
15 17
16 26
17 114
18 30
19 47
20 28

About Isabelle Aubry

Isabelle Aubry is a scholar working on Toxicology, Immunology and Ophthalmology, having authored 26 papers that have together received 468 indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (14 papers), Galectins and Cancer Biology (6 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Rheumatology (113 citations), Toxicology (22 citations) and Ophthalmology (43 citations). Isabelle Aubry has collaborated with scholars based in Canada, United States and France. Frequent co-authors include Michel L. Tremblay, Daniel Lajeunesse, Aline Delalandre, Jean‐Pierre Pelletier, Johanne Martel‐Pelletier, Martin Lavigne, Denis Couchourel, Abhijeet S. Kate, Russell G. Kerr and Julio Fernandes. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026